Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the School of Medicine and Cedars-Sinai suggests.
Researchers have discovered a way to predict which patients with severe COVID-19 are likely to recover well and which are likely to suffer “long-haul” lung problems. That finding could help doctors personalize treatments for patients.
The rate of suspected suicide attempts by poisoning among children and adolescents ages 10-19 reported to U.S. poison centers increased 30% during 2021 – the COVID-19 pandemic’s first full year – compared with 2019, a new UVA Health study found.